Alert: Major Price Decline (3/31/25)-Catalyst Biosciences Inc (NASDAQ: GYRE).

out_logo_500#72885.jpg

On 3/31/25, Catalyst Biosciences Inc (NASDAQ: GYRE) stock suffered a major decline of -15.3%, closing at $7.72. Moreover, trading volume in this decline was exceptionally high at 326% of normal. Relative to the market the stock has been weak over the last nine months and has declined -20.5% during the last week.

out_mm#72885.jpg

Current PriceTarget Research Rating

Catalyst Biosciences is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*